Robert A Holt Selected Research

Robert A Holt Research Topics

Disease

23	Neoplasms (Cancer) 09/2022 - 10/2009
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 02/2012
3	Malignant Mesothelioma 01/2020 - 01/2017
2	Inflammation (Inflammations) 10/2021 - 01/2020
2	Infections 01/2020 - 05/2003
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2016
2	Adenocarcinoma 01/2015 - 01/2010
2	Schizophrenia (Dementia Praecox) 06/2010 - 03/2006
2	Neoplasm Metastasis (Metastasis) 01/2010 - 10/2009
1	Chordoma 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Lung Neoplasms (Lung Cancer) 04/2017
1	Mesothelioma 01/2017
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	sporadic Papillary renal cell carcinoma 01/2016
1	Microcephaly 01/2016
1	Glioma (Gliomas) 06/2015
1	Hydatidiform Mole (Molar Pregnancy) 01/2015
1	Neuroinflammatory Diseases 04/2011
1	Amyloid Plaque 09/2010
1	Prostatic Neoplasms (Prostate Cancer) 10/2009
1	Disease Progression 10/2009
1	Shock 11/2008
1	Hypoxia (Hypoxemia) 04/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2007
1	Intellectual Disability (Idiocy) 09/2006
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2006

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 01/2018 - 02/2012
5	VaccinesIBA 01/2020 - 05/2003
5	AntigensIBA 01/2020 - 05/2014
5	Proteins (Proteins, Gene)FDA Link 06/2015 - 11/2008
4	Chimeric Antigen ReceptorsIBA 09/2022 - 12/2017
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2009
4	Peptides (Polypeptides)IBA 01/2019 - 03/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2006
4	EpitopesIBA 01/2016 - 05/2003
3	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2015
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2010
2	AsbestosIBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2016 - 06/2015
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	NivolumabIBA 12/2021
1	Brachyury protein (Brachyury)IBA 12/2021
1	ChemokinesIBA 10/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021
1	Ephrin-A1 (Ephrin A1)IBA 10/2021
1	pembrolizumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	CarcinogensIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 04/2017
1	AntibodiesIBA 04/2017
1	B7-H1 AntigenIBA 04/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Diphtheria ToxinIBA 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Fumarate Hydratase (Fumarase)IBA 01/2016
1	Long Noncoding RNAIBA 01/2015
1	IgKIBA 01/2015
1	HLA-A Antigens (HLA-A)IBA 05/2014
1	Glycoproteins (Glycoprotein)IBA 04/2011
1	syncytinIBA 04/2011
1	Amyloid beta-PeptidesIBA 09/2010
1	DysbindinIBA 06/2010
1	ChaperoninsIBA 06/2010
1	Adaptor Protein Complex 3IBA 06/2010
1	Dynactin ComplexIBA 06/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2010
1	Phosphotransferases (Kinase)IBA 01/2010
1	Sorafenib (BAY 43-9006)FDA Link 01/2010
1	Sulindac (Copal)FDA LinkGeneric 01/2010
1	AndrogensIBA 10/2009
1	NucleotidesIBA 10/2009
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2008
1	TCF Transcription FactorsIBA 04/2008
1	polyglutamineIBA 05/2007
1	OligonucleotidesIBA 09/2006
1	Glutamic Acid (Glutamate)FDA Link 03/2006
1	Antiviral Agents (Antivirals)IBA 05/2003
1	Neutralizing AntibodiesIBA 05/2003

Therapy/Procedure

11	Therapeutics 09/2022 - 10/2009
7	Immunotherapy 01/2020 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Ligation 01/2016
1	Aftercare (After-Treatment) 01/2010